Announcement of important resolutions of the
Company's 2022 General Shareholders'Meeting
Date of events
2022/06/23
To which item it meets
paragraph 18
Statement
1.Date of the shareholders' meeting:2022/06/23
2.Important resolutions I.Profit distribution/deficit compensation:
Acknowledgment of the 2021 Earnings Distribution.
3.Important resolutions II.Amendments of the company charter:
Acknowledgment of amendments of the Company's Articles of Incorporation
4.Important resolutions III.Business report and financial statements:
Acknowledgment of the 2021 business report and financial statements.
5.Important resolutions IV.Election for directors and supervisors:N/A
6.Important resolutions V.Other matters:
(1) Discussion on the new share issuance through capitalization of retained
earnings: Approved.
(2) Discussion of amendments of the Company's Procedures for Acquisition or
Disposal of Assets:Approved.
7.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Universal Vision Biotechnology Co. Ltd. published this content on 23 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 June 2022 09:44:02 UTC.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD is a Taiwan-based company principally engaged in the trading of ophthalmic supplies and the provision of eye treatment and related medical services. The Company provides laser vision correction equipment and services, as well as the trading of medical drugs, optical glasses and contact lenses. In addition, the Company is involved in the leasing of medical places, the planning of clinic operation, as well as the provision of medical cosmetology services. The Company operates its businesses mainly in Taiwan market.
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. 
